Sugi Predict

Sugi Predict / Compounds / SCHEMBL30014930

SCHEMBL30014930

SCHEMBL30014930

CC(=O)N[C@H]1[C@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO[C@]2(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O2)O[C@H](CO)[C@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.66

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ SIGLEC7 Q9Y286 6/20 0.66
▸ MAG P20916 8/20 0.64
▸ SELL P14151 1/20 0.60
▸ SELP P16109 1/20 0.60
▸ SELE P16581 1/20 0.50
▸ CD22 P20273 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31700860 0.99 SIGLEC7 (0.68) SIGLEC7MAGSELLSELPSELE
SCHEMBL30653986 0.97 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL31717064 0.97 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL29632860 0.97 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL31717039 0.97 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL31700356 0.97 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL31700317 0.97 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL29483497 0.97 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL30894716 0.97 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL30970760 0.96 SIGLEC7 (0.70) SIGLEC7MAGSELLSELPSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11965023-B2 Anti-Siglec-5 antibodies and methods of use thereof ALECTOR LLC (US) 2024-04-23 — — US disclosed
US-20220315656-A1 ANTI-SIGLEC-5 ANTIBODIES AND METHODS OF USE THEREOF ALECTOR LLC (US) 2022-10-06 — — US disclosed
Send feedback